ROSUVASTATIN NOBEL cpr pell 5 mg bte 190 pce

7680676050092 CH-67605 C10AA07 07.12.0.

Active substances:

ROSUVASTATIN NOBEL cpr pell 5 mg bte 190 pce
ROSUVASTATIN NOBEL cpr pell 5 mg bte 190 pce
ROSUVASTATIN NOBEL cpr pell 5 mg bte 190 pce
1 / 3
google

Details

Product number
6760501
CPT
-
Packaging group
190
Unit
Tablette(n)
Composition
rosuvastatinum 5 mg ut rosuvastatinum calcicum, lactosum monohydricum 47.696 mg, calcii carbonas, cellulosum microcristallinum, crospovidonum, hydroxypropylcellulosum, magnesii stearas, aqua purificata, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, copovidonum, E 171, kaolinum ponderosum, natrii laurilsulfas, E 110 5.9 µg, E 104, poly(alcohol vinylicus), silica colloidalis anhydrica, talcum, pro compresso obducto corresp. natrium 3 µg.

Articles (1)

Rosuvastatin NOBEL 5 mg, Filmtabletten
Filmtabletten
190
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/03/2026
Patient information leaflet
Français
10/03/2026
Patient information leaflet
Italien
10/03/2026
Professional SmPC
Allemand
07/03/2026
Professional SmPC
Français
07/03/2026
Professional SmPC
Italien
07/03/2026

Detailed composition

Substance Quantity Type Category
rosuvastatinum
5.0 MG Substance Wirkstoff (Principe actif)
rosuvastatinum calcicum
- Substance WIZUS
lactosum monohydricum
47.696 MG Substance HBESI
calcii carbonas
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
crospovidonum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
aqua purificata
- Substance HNIDK
copolymerum macrogolo et alcoholi poly(vinylico) constatum
- Substance HNIDK
copovidonum
- Substance HNIDK
E 171
- Substance FNIDK
kaolinum ponderosum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 110
5.9 UG Substance HBESI
E 104
- Substance FIMDK
poly(alcohol vinylicus)
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
talcum
- Substance HNIDK
natrium
3.0 UG Substance HBESI

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67605
Drug name
Rosuvastatin NOBEL, Filmtabletten
Galenic form
FILM
ATC Code
C10AA07
Authorization status
Z
Dispensation category
B
First authorization
16/12/2019
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration. Vorbeugung kardiovaskulärer Ereignisse bei Erwachsenen mit normalem LDL-Cholesterin Spiegel und erhöhtem Risiko von atherosklerotischen kardiovaskulären Erkrankungen.

Packaging details

Description (FR)
ROSUVASTATIN NOBEL cpr pell 5 mg bte 190 pce
Description (DE)
ROSUVASTATIN NOBEL Filmtabl 5 mg Ds 190 Stk
Market launch
16/12/2019
Narcotic (BTM)
No

Available generics

Crestastatin, Filmtabletten
CHF 16.95
View
Crestastatin, Filmtabletten
CHF 42.20
View
Crestastatin, Filmtabletten
CHF 18.05
View
Crestastatin, Filmtabletten
CHF 45.80
View
Crestastatin, Filmtabletten
CHF 29.20
View
Crestastatin, Filmtabletten
CHF 59.05
View
Rosuvastatin Axapharm, Filmtabletten
CHF 16.95
View
Rosuvastatin Axapharm, Filmtabletten
CHF 42.20
View
Rosuvastatin Axapharm, Filmtabletten
CHF 18.05
View
Rosuvastatin Axapharm, Filmtabletten
CHF 45.80
View

Other packaging sizes

ROSUVASTATIN NOBEL cpr pell 5 mg 30 pce
30 TABL
View
ROSUVASTATIN NOBEL cpr pell 5 mg 105 pce
105 TABL
View
ROSUVASTATIN NOBEL cpr pell 10 mg 30 pce
30 TABL
View
ROSUVASTATIN NOBEL cpr pell 10 mg 105 pce
105 TABL
View
ROSUVASTATIN NOBEL cpr pell 10 mg bte 190 pce
190 TABL
View
ROSUVASTATIN NOBEL cpr pell 20 mg 30 pce
30 TABL
View
ROSUVASTATIN NOBEL cpr pell 20 mg 105 pce
105 TABL
View
ROSUVASTATIN NOBEL cpr pell 20 mg bte 120 pce
120 TABL
View
Buy us a coffee Explore the data